Cancer peptide vaccine therapy for patients with advanced metastatic colorectal cancer. Phase I/II clinical trial.

ABSTRACT: Interventions: Subcutaneous injection of cancer peptide vaccines (five peptides) Primary outcome(s): Safety Responsiveness (tumor size) Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Cancer

PROVIDER: 2620388 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR